20/30 Labs Limited

POWER SEARCH PRICING

SOLUTIONS

20/30 labs limited Company Information

Company Number

06178552

Next Accounts

Jun 2025

Directors

Mett Lindsay-Smart

Anthony Laughton

View All

Shareholders

mett lindsay-smart

Group Structure

View All

Industry

Technical testing and analysis

Registered Address

1-2 charterhouse mews, london, EC1M 6BB

Website

www.2030lab.com

20/30 labs limited Estimated Valuation

£4.4m

Pomanda estimates the enterprise value of 20/30 LABS LIMITED at £4.4m based on a Turnover of £4.5m and 0.96x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

20/30 Labs Limited is a live company located in london, EC1M 6BB with a Companies House number of 06178552. It operates in the technical testing and analysis sector, SIC Code 71200. Founded in March 2007, it's largest shareholder is mett lindsay-smart with a 100% stake. 20/30 Labs Limited is a established, small sized company, Pomanda has estimated its turnover at £4.5m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded 20/30 Labs Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating4.5out of 5

4 Strong

5 Regular

3 Weak

Size

annual sales of £4.5m, make it in line with the average company (£4.5m)

Growth

3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (3.3%)

EXPORT

20/30 Labs Limited's latest turnover from September 2023 is estimated at £4.5 million and the company has net assets of £1.4 million. According to their latest financial statements, 20/30 Labs Limited has 45 employees and maintains cash reserves of £805.2 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	4,515,729	5,530,362	5,344,130	5,252,597	3,877,269	3,366,638	2,800,351	3,244,322	2,633,361	2,475,640	1,680,495	1,832,607	1,283,661	972,125
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	2,485,059	2,963,861	2,757,796	2,733,221	1,974,701	1,845,753	1,476,153	1,521,658	1,221,175	1,090,741	750,825	890,815	640,605	470,639
Gross Profit	2,030,671	2,566,501	2,586,334	2,519,376	1,902,567	1,520,885	1,324,198	1,722,664	1,412,187	1,384,899	929,669	941,791	643,056	501,487
Admin Expenses	2,996,626	2,877,013	242,287	2,087,949	2,078,551	1,489,875	1,465,179	1,461,782	1,441,785	1,157,902	1,000,782	856,254	521,981	176,920
Operating Profit	-965,955	-310,512	2,344,047	431,427	-175,984	31,010	-140,981	260,882	-29,598	226,997	-71,113	85,537	121,075	324,567
Interest Payable	0	0	7,727	7,727	0	0	0	0	0	0	0	0	0	0
Interest Receivable	50,566	46,535	1,760	260	277	326	255	1,106	1,167	547	359	504	407	107
Pre-Tax Profit	-915,389	-263,977	2,338,080	423,960	-175,707	31,336	-140,726	261,989	-28,431	227,544	-70,754	86,041	121,482	324,674
Tax	0	0	-444,235	-80,552	0	-5,954	0	-52,398	0	-52,335	0	-22,371	-34,015	-90,909
Profit After Tax	-915,389	-263,977	1,893,845	343,408	-175,707	25,382	-140,726	209,591	-28,431	175,209	-70,754	63,670	87,467	233,765
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-915,389	-263,977	1,893,845	343,408	-175,707	25,382	-140,726	209,591	-28,431	175,209	-70,754	63,670	87,467	233,765
Employee Costs	2,012,143	2,537,030	2,647,428	2,196,087	1,784,566	1,440,503	1,103,688	1,346,435	1,089,000	1,077,640	754,402	826,808	546,228	413,833
Number Of Employees	45	60	66	52	45	38	30	39	30	31	23	25	17	13
EBITDA*	-799,373	-152,200	2,494,046	565,050	-112,786	105,979	-63,480	378,707	76,750	322,715	-21,220	236,260	149,686	360,147

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	511,171	583,140	622,245	343,543	210,531	255,265	298,477	336,893	319,467	287,153	166,891	150,723	113,359	136,090
Intangible Assets	5,469	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	145,713	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	516,640	583,140	622,245	489,256	210,531	255,265	298,477	336,893	319,467	287,153	166,891	150,723	113,359	136,090
Stock & work in progress	339,276	106,129	139,892	31,999	7,410	7,410	5,379	4,963	5,066	5,122	4,783	4,290	3,310	2,969
Trade Debtors	770,098	1,091,413	1,046,482	1,103,800	787,755	751,968	624,866	712,675	511,749	508,918	365,905	359,323	225,434	164,206
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	432,590	301,607	132,307	104,444	0	0	0	0	0	69,103	121,103	165,295	113,055	134,474
Cash	805,216	1,121,093	3,015,387	504,999	15,519	58,399	71,989	132,229	310,315	156,509	62,354	81,205	120,290	42,683
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	2,347,180	2,620,242	4,334,068	1,745,242	810,684	817,777	702,234	849,867	827,130	739,652	554,145	610,113	462,089	344,332
total assets	2,863,820	3,203,382	4,956,313	2,234,498	1,021,215	1,073,042	1,000,711	1,186,760	1,146,597	1,026,805	721,036	760,836	575,448	480,422
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	24,166	0	0	0	0	0	0	0	0	0	0
Trade Creditors	518,800	265,351	305,663	518,920	627,916	447,905	383,832	414,650	565,973	371,254	329,708	315,924	242,268	215,703
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	782,958	477,558	1,918,594	728,629	0	0	0	0	0	0	0	0	0	0
total current liabilities	1,301,758	742,909	2,224,257	1,271,715	627,916	447,905	383,832	414,650	565,973	371,254	329,708	315,924	242,268	215,703
loans	0	0	0	229,167	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	10,242	13,333	33,552	41,295	49,413	82,535	133,361	65,897	48,084	3,588	20,710
provisions	124,154	107,176	114,782	0	0	35,912	45,293	51,680	36,663	32,333	10,783	11,426	7,860	9,744
total long term liabilities	124,154	107,176	114,782	239,409	13,333	69,464	86,588	101,093	119,198	165,694	76,680	59,510	11,448	30,454
total liabilities	1,425,912	850,085	2,339,039	1,511,124	641,249	517,369	470,420	515,743	685,171	536,948	406,388	375,434	253,716	246,157
net assets	1,437,908	2,353,297	2,617,274	723,374	379,966	555,673	530,291	671,017	461,426	489,857	314,648	385,402	321,732	234,265
total shareholders funds	1,437,908	2,353,297	2,617,274	723,374	379,966	555,673	530,291	671,017	461,426	489,857	314,648	385,402	321,732	234,265

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-965,955	-310,512	2,344,047	431,427	-175,984	31,010	-140,981	260,882	-29,598	226,997	-71,113	85,537	121,075	324,567
Depreciation	164,956	158,312	149,999	133,623	63,198	74,969	77,501	117,825	106,348	95,718	49,893	150,723	28,611	35,580
Amortisation	1,626	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	-444,235	-80,552	0	-5,954	0	-52,398	0	-52,335	0	-22,371	-34,015	-90,909
Stock	233,147	-33,763	107,893	24,589	0	2,031	416	-103	-56	339	493	980	341	2,969
Debtors	-190,332	214,231	-175,168	566,202	35,787	127,102	-87,809	200,926	-66,272	91,013	-37,610	186,129	39,809	298,680
Creditors	253,449	-40,312	-213,257	-108,996	180,011	64,073	-30,818	-151,323	194,719	41,546	13,784	73,656	26,565	215,703
Accruals and Deferred Income	305,400	-1,441,036	1,189,965	728,629	0	0	0	0	0	0	0	0	0	0
Deferred Taxes & Provisions	16,978	-7,606	114,782	0	-35,912	-9,381	-6,387	15,017	4,330	21,550	-643	3,566	-1,884	9,744
Cash flow from operations	-266,361	-1,821,622	3,208,576	513,340	-4,474	25,584	-13,292	-10,820	342,127	242,124	29,038	104,002	100,202	193,036
Investing Activities
capital expenditure	-100,082	-119,207	-428,701	-266,635	-18,464	-31,757	-39,085	-135,251	-138,662	-215,980	-66,061	-188,087	-5,880	-171,670
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-100,082	-119,207	-428,701	-266,635	-18,464	-31,757	-39,085	-135,251	-138,662	-215,980	-66,061	-188,087	-5,880	-171,670
Financing Activities
Bank loans	0	0	-24,166	24,166	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	-229,167	229,167	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	-10,242	-3,091	-20,219	-7,743	-8,118	-33,122	-50,826	67,464	17,813	44,496	-17,122	20,710
share issue	0	0	55	0	0	0	0	0	0	0	0	0	0	500
interest	50,566	46,535	-5,967	-7,467	277	326	255	1,106	1,167	547	359	504	407	107
cash flow from financing	50,566	46,535	-269,487	242,775	-19,942	-7,417	-7,863	-32,016	-49,659	68,011	18,172	45,000	-16,715	21,317
cash and cash equivalents
cash	-315,877	-1,894,294	2,510,388	489,480	-42,880	-13,590	-60,240	-178,086	153,806	94,155	-18,851	-39,085	77,607	42,683
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-315,877	-1,894,294	2,510,388	489,480	-42,880	-13,590	-60,240	-178,086	153,806	94,155	-18,851	-39,085	77,607	42,683

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for 20/30 labs limited. Get real-time insights into 20/30 labs limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for 20/30 labs limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EC1M area or any other competitors across 12 key performance metrics.

20/30 LABS LIMITED group structure

20/30 Labs Limited has 1 subsidiary company.

Ultimate parent company

20/30 LABS LIMITED

06178552

1 subsidiary

MS LAB PRODUCTS LIMITED

11017900

20/30 LABS LIMITED Shareholders

mett lindsay-smart

100%

20/30 Labs Limited currently has 5 directors. The longest serving directors include Mrs Mett Lindsay-Smart (Mar 2007) and Mr Anthony Laughton (Mar 2021).

officer	country	age	start	end	role
Mrs Mett Lindsay-Smart		46 years	Mar 2007	-	Director
Mr Anthony Laughton	England	41 years	Mar 2021	-	Director
Ms Britt Schuurs	England	36 years	Aug 2024	-	Director
Joep Bruins	England	52 years	Aug 2024	-	Director
Mr Vincent Bremmer	Netherlands	50 years	Jan 2025	-	Director

P&L

September 2023

turnover

4.5m

-18%

operating profit

-966k

gross margin

45%

-3.1%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

September 2023

net assets

1.4m

-0.39%

total assets

2.9m

-0.11%

cash

805.2k

-0.28%

net assets

Total assets minus all liabilities

Similar Companies

borchers catalyst (uk) limited

metrology & quality services limited

4.5

jsb uk and ireland ltd

structural diagnostics limited

2.5

eurofins biopharma product testing uk limited

1.5

company number

06178552

Type

Private limited with Share Capital

industry

71200 - Technical testing and analysis

incorporation date

March 2007

ultimate parent company

None

previous names

N/A

address

1-2 charterhouse mews, london, EC1M 6BB

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to 20/30 labs limited. Currently there are 0 open charges and 1 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for 20/30 LABS LIMITED. This can take several minutes, an email will notify you when this has completed.

20/30 labs limited Company Information

20/30 labs limited Estimated Valuation

20/30 labs limited Estimated Valuation

20/30 labs limited Estimated Valuation

20/30 Labs Limited Overview

20/30 Labs Limited Health Check

20/30 LABS LIMITED financials

20/30 labs limited Credit Report and Business Information

20/30 Labs Limited Competitor Analysis

20/30 labs limited Ownership

20/30 labs limited directors

20/30 labs limited company details

20/30 labs limited Charges & Mortgages

20/30 labs limited Capital Raised & Share Issues BETA

20/30 labs limited Companies House Filings - See Documents